Successful trial for plaque psoriasis treatment
Israel’s Scinai Immunotherapeutics has announced successful preclinical trial results of its innovative anti‑IL‑17 VHH antibody (‘NanoAb’) as a local treatment for the large and underserved population of patients with mild to moderate plaque psoriasis.
This entry was posted in Israel's Medical Achievements
. Bookmark the permalink